easyhaler budesonide 200micrograms/dose dry powder inhaler
orion pharma (uk) ltd - budesonide - inhalation powder - 200microgram/1dose
eldepryl 5mg tablets
orion pharma (uk) ltd - selegiline hydrochloride - oral tablet - 5mg
eldepryl 10mg tablets
orion pharma (uk) ltd - selegiline hydrochloride - oral tablet - 10mg
sandrena 500microgram gel sachets
orion pharma (uk) ltd - estradiol hemihydrate - transdermal gel - 500microgram
sandrena 1mg gel sachets
orion pharma (uk) ltd - estradiol hemihydrate - transdermal gel - 1mg
methotrexate orion 2.5 mg tablets
orion corporation - methotrexate - tablet - 2.5 milligram(s) - folic acid analogues; methotrexate; other immunosuppressants; methotrexate
methotrexate orion 10 mg tablets
orion corporation - methotrexate - tablet - 10 milligram(s) - folic acid analogues; methotrexate; other immunosuppressants; methotrexate
tridestra tablets
orion pharma (uk) ltd - not applicable
simdax
orion pharma (nz) limited - levosimendan 2.5 mg/ml - concentrate for infusion - 2.5 mg/ml - active: levosimendan 2.5 mg/ml excipient: citric acid ethanol povidone - simdax is indicated for the short-term treatment of acutely decompensated chronic heart failure (adhf) in situations where conventional therapy is not sufficient, and in cases where inotropic support is considered appropriate.
comtan
orion pharma (nz) limited - entacapone 200mg - film coated tablet - 200 mg - active: entacapone 200mg excipient: croscarmellose sodium ethanol glycerol hydrogenated vegetable oil hypromellose iron oxide red iron oxide yellow magnesium stearate mannitol microcrystalline cellulose polysorbate 80 purified water sucrose titanium dioxide - entacapone is indicated as an adjunct to standard preparations of levodopa/benserazide or levodopa/carbidopa for use in patients with parkinson's disease and end-of-dose motor fluctuations, who cannot be stabilized on those combinations.